Dalton CIO, James B. Rosenwald III, recently interviewed with Nikkei Business, discussing recent announcements by Aska Pharmaceutical and Bunka Shutter to potentially implement a poison pill in order to block shareholder efforts to have . . .
Dalton Chief Investment Officer Interviewed by Nikkei Business on Why Poison Pills Do Not Work
Posted October 2, 2025